An analysis of 27 years of “ongoing, systematic wrongdoing” by the pharmaceutical industry reveals the U.S. Department of Justice has levied billions of dollars worth of fines against pharma companies, often under the False Claims Act. The fines support government budgets but do nothing to reform the industry’s criminal behavior.
top of page
To see this working, head to your live site.
2294. Pharma’s Criminal Business Model — and How the U.S. Government Benefits From It
2294. Pharma’s Criminal Business Model — and How the U.S. Government Benefits From It
0 comments
Like
Comments (0)
Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page